
UnitedHealth Group (UNH) Stock Forecast & Price Target
UnitedHealth Group (UNH) Analyst Ratings
Bulls say
UnitedHealth Group demonstrates a positive financial outlook, with overall earnings projected to grow 13% in 2026, primarily due to margin improvements within the Medicare and commercial segments. The company's Optum franchises are expected to contribute significantly, with Optum Health earnings anticipated to grow approximately 9% and overall margins expanding across its three business segments. Additionally, effective vertical integration enhances UnitedHealth's competitive positioning and supports its substantial scale in the medical insurance market.
Bears say
The analysis indicates a negative outlook for UnitedHealth Group, driven primarily by anticipated declines in membership across multiple segments, particularly in Medicare Advantage (MA) and Medicaid, where member counts are projected to shrink significantly by 1.3-1.4 million and 300,000 respectively due to factors such as increased plan shopping and policy changes. Furthermore, the expected decrease in MA reimbursement rates in FY2027, which is approximately 0.09% and significantly below initial optimistic forecasts, adds pressure to profitability as margins are predicted to fall, particularly in Medicaid where margins could drop from -0.1% to -1.8%. Lastly, the company faces potential political challenges as reimbursement rates are under scrutiny, with the threat of further declines in stakeholder trust if they are unable to align rates with inflationary trends and rising utilization demands.
This aggregate rating is based on analysts' research of UnitedHealth Group and is not a guaranteed prediction by Public.com or investment advice.
UnitedHealth Group (UNH) Analyst Forecast & Price Prediction
Start investing in UnitedHealth Group (UNH)
Order type
Buy in
Order amount
Est. shares
0 shares